Matches in SemOpenAlex for { <https://semopenalex.org/work/W2557109620> ?p ?o ?g. }
- W2557109620 abstract "Abstract Abstract 862 NFAT is a family of highly phosphorylated proteins residing in the cytoplasm of resting cells. Upon dephosphorylation by calcineurin, NFAT proteins translocate to the nucleus where they orchestrate developmental and activation programs in diverse cell types. NFAT is inactivated and relocated to the cytoplasm by a network of several kinases. Although identified originally as a major transcriptional regulator in T cells, it is now clear that NFAT transcription factors also possess important roles in other cells of the hematopoietic system including dendritic cells, mast cells, megakaryocytes and B cells. Several recent studies have demonstrated that Calcineurin/NFAT signaling is involved in the pathogenesis of a wide array of hematological malignancies including diffuse large B cell lymphoma, CLL as well as Burkitt and Burkitt-like lymphomas. Here, we analyzed the role of NFAT2 in the pathogenesis of B-CLL. For this purpose, we generated mice with a conditional NFAT2 knock out allele (NFAT2fl/fl). In order to achieve NFAT2 deletion limited to the B cell lineage, we bred NFAT2fl/fl mice to CD19-Cre mice, in which the Cre recombinase is expressed under the control of the B cell-specific CD19 promoter. To investigate the role of NFAT2 in the pathogenesis of CLL we made use of the Eμ-TCL1 transgenic mouse model in which the TCL1 oncogene is expressed under the control of the Eμ enhancer. TCL1 transgenic mice develop a human-like CLL at the age of approximately 14 weeks to which the animals eventually succumb at an average age of 10 months. To analyze the role of NFAT2 in CLL, we generated mice (n=10) whose B cells exhibited a specific deletion of this transcription factor in addition to their transgenic expression of the TCL1 oncogene (TCL1 CD19-Cre NFAT2fl/fl). TCL1 transgenic mice without an NFAT2 deletion served as controls (n=10). Mice with NFAT2 knock out exhibited a significantly accelerated accumulation of CD5+CD19+ CLL cells as compared to control animals. Flow cytometric analysis at distinct time points showed a tremendous infiltration by CD5+ B cells in the peritoneal cavity, spleen, lymph nodes, liver and bone marrow which was significantly stronger in the NFAT2 ko cohort. Most of the CD5+ B cells in TCL1+NFAT2 ko mice showed high expression of ZAP70 and CD38, whereas TCL1 transgenic mice only demonstrated very few CD5+ B cells with concomitant expression of ZAP70 and CD38. At approximately 26 weeks of age, NFAT2 ko mice showed an approximately 40 fold increased lymphocyte count in the peripheral blood than their litter mate controls (1500/μL vs. 60000/μL). Splenomegaly and lymphatic adenopathy was also significantly increased in the NFAT ko population. Furthermore, NFAT2 ko mice showed a dramatically reduced median survival (200 vs. 325 days) and maximum survival (265 vs. 398 days) in comparison to regular TCL1 transgenic mice. To investigate the effects of an NFAT2 ko on proliferation and apoptosis of CD5+CD19+ CLL cells, we performed in vivo BrdU incorporation assays with subsequent flow cytometric analysis. Interestingly, we could show that CLL cells isolated from spleens, bone marrow and peripheral blood from mice with an NFAT ko at an age of approximately 7 months exhibited significantly higher rates of proliferation than control animals. In summary, our data provide strong evidence that NFAT2 is a critical regulator of CD38 and ZAP70 expression and substantially controls cell cycle progression in CLL cells implicating Ca2+/NFAT signaling as a potential target for the treatment of this disease. Disclosures: No relevant conflicts of interest to declare." @default.
- W2557109620 created "2016-11-30" @default.
- W2557109620 creator A5007788664 @default.
- W2557109620 creator A5031869321 @default.
- W2557109620 creator A5034088043 @default.
- W2557109620 creator A5036009814 @default.
- W2557109620 creator A5039927433 @default.
- W2557109620 creator A5051771947 @default.
- W2557109620 creator A5066624700 @default.
- W2557109620 creator A5080472610 @default.
- W2557109620 creator A5090585459 @default.
- W2557109620 creator A5090740852 @default.
- W2557109620 date "2012-11-16" @default.
- W2557109620 modified "2023-09-27" @default.
- W2557109620 title "Genetic Loss of NFAT2 Induces Profound Acceleration of CLL in the TCL1 Mouse Model" @default.
- W2557109620 doi "https://doi.org/10.1182/blood.v120.21.862.862" @default.
- W2557109620 hasPublicationYear "2012" @default.
- W2557109620 type Work @default.
- W2557109620 sameAs 2557109620 @default.
- W2557109620 citedByCount "1" @default.
- W2557109620 countsByYear W25571096202022 @default.
- W2557109620 crossrefType "journal-article" @default.
- W2557109620 hasAuthorship W2557109620A5007788664 @default.
- W2557109620 hasAuthorship W2557109620A5031869321 @default.
- W2557109620 hasAuthorship W2557109620A5034088043 @default.
- W2557109620 hasAuthorship W2557109620A5036009814 @default.
- W2557109620 hasAuthorship W2557109620A5039927433 @default.
- W2557109620 hasAuthorship W2557109620A5051771947 @default.
- W2557109620 hasAuthorship W2557109620A5066624700 @default.
- W2557109620 hasAuthorship W2557109620A5080472610 @default.
- W2557109620 hasAuthorship W2557109620A5090585459 @default.
- W2557109620 hasAuthorship W2557109620A5090740852 @default.
- W2557109620 hasConcept C102230213 @default.
- W2557109620 hasConcept C104317684 @default.
- W2557109620 hasConcept C125929170 @default.
- W2557109620 hasConcept C128057223 @default.
- W2557109620 hasConcept C141035611 @default.
- W2557109620 hasConcept C141071460 @default.
- W2557109620 hasConcept C159654299 @default.
- W2557109620 hasConcept C189938988 @default.
- W2557109620 hasConcept C203014093 @default.
- W2557109620 hasConcept C2776090121 @default.
- W2557109620 hasConcept C2778453870 @default.
- W2557109620 hasConcept C2778957590 @default.
- W2557109620 hasConcept C2780942790 @default.
- W2557109620 hasConcept C2911091166 @default.
- W2557109620 hasConcept C502942594 @default.
- W2557109620 hasConcept C54355233 @default.
- W2557109620 hasConcept C71924100 @default.
- W2557109620 hasConcept C86339819 @default.
- W2557109620 hasConcept C86803240 @default.
- W2557109620 hasConcept C8891405 @default.
- W2557109620 hasConcept C95444343 @default.
- W2557109620 hasConcept C96926380 @default.
- W2557109620 hasConceptScore W2557109620C102230213 @default.
- W2557109620 hasConceptScore W2557109620C104317684 @default.
- W2557109620 hasConceptScore W2557109620C125929170 @default.
- W2557109620 hasConceptScore W2557109620C128057223 @default.
- W2557109620 hasConceptScore W2557109620C141035611 @default.
- W2557109620 hasConceptScore W2557109620C141071460 @default.
- W2557109620 hasConceptScore W2557109620C159654299 @default.
- W2557109620 hasConceptScore W2557109620C189938988 @default.
- W2557109620 hasConceptScore W2557109620C203014093 @default.
- W2557109620 hasConceptScore W2557109620C2776090121 @default.
- W2557109620 hasConceptScore W2557109620C2778453870 @default.
- W2557109620 hasConceptScore W2557109620C2778957590 @default.
- W2557109620 hasConceptScore W2557109620C2780942790 @default.
- W2557109620 hasConceptScore W2557109620C2911091166 @default.
- W2557109620 hasConceptScore W2557109620C502942594 @default.
- W2557109620 hasConceptScore W2557109620C54355233 @default.
- W2557109620 hasConceptScore W2557109620C71924100 @default.
- W2557109620 hasConceptScore W2557109620C86339819 @default.
- W2557109620 hasConceptScore W2557109620C86803240 @default.
- W2557109620 hasConceptScore W2557109620C8891405 @default.
- W2557109620 hasConceptScore W2557109620C95444343 @default.
- W2557109620 hasConceptScore W2557109620C96926380 @default.
- W2557109620 hasLocation W25571096201 @default.
- W2557109620 hasOpenAccess W2557109620 @default.
- W2557109620 hasPrimaryLocation W25571096201 @default.
- W2557109620 hasRelatedWork W1999306221 @default.
- W2557109620 hasRelatedWork W2006176743 @default.
- W2557109620 hasRelatedWork W2069595349 @default.
- W2557109620 hasRelatedWork W2073635971 @default.
- W2557109620 hasRelatedWork W2140764496 @default.
- W2557109620 hasRelatedWork W2331111726 @default.
- W2557109620 hasRelatedWork W2403091260 @default.
- W2557109620 hasRelatedWork W2529009564 @default.
- W2557109620 hasRelatedWork W2535084911 @default.
- W2557109620 hasRelatedWork W2548434728 @default.
- W2557109620 hasRelatedWork W2556497985 @default.
- W2557109620 hasRelatedWork W2558094855 @default.
- W2557109620 hasRelatedWork W2586225271 @default.
- W2557109620 hasRelatedWork W2586832877 @default.
- W2557109620 hasRelatedWork W2587589218 @default.
- W2557109620 hasRelatedWork W2594884466 @default.
- W2557109620 hasRelatedWork W2906214504 @default.
- W2557109620 hasRelatedWork W2980926250 @default.
- W2557109620 hasRelatedWork W2982197579 @default.
- W2557109620 hasRelatedWork W3211109518 @default.
- W2557109620 isParatext "false" @default.